nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.0334	0.13	CbGpPWpGaD
Travoprost—PTGFR—Prostanoid ligand receptors—PTGER4—multiple sclerosis	0.0307	0.119	CbGpPWpGaD
Travoprost—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—multiple sclerosis	0.0204	0.0794	CbGpPWpGaD
Travoprost—PTGFR—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.0169	0.0657	CbGpPWpGaD
Travoprost—PTGFR—Small Ligand GPCRs—CNR1—multiple sclerosis	0.0146	0.057	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.0117	0.0456	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—S1PR1—multiple sclerosis	0.00954	0.0371	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CXCR3—multiple sclerosis	0.00466	0.0181	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00432	0.0168	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CNR1—multiple sclerosis	0.00418	0.0163	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00387	0.015	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00355	0.0138	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00334	0.013	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00306	0.0119	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CCR5—multiple sclerosis	0.00292	0.0114	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00286	0.0111	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—S1PR1—multiple sclerosis	0.0027	0.0105	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00262	0.0102	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00262	0.0102	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GPR65—multiple sclerosis	0.00218	0.00848	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.0021	0.00815	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00202	0.00787	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR1—multiple sclerosis	0.00199	0.00775	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL13—multiple sclerosis	0.00199	0.00775	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00197	0.00766	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00187	0.00726	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00182	0.00707	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.0018	0.00698	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00173	0.00675	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00169	0.00656	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00156	0.00606	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00153	0.00594	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL3—multiple sclerosis	0.00142	0.00552	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.0014	0.00545	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—S1PR1—multiple sclerosis	0.00139	0.0054	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—PTGER4—multiple sclerosis	0.00137	0.00532	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCR3—multiple sclerosis	0.00132	0.00514	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—RGS1—multiple sclerosis	0.0013	0.00505	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR2—multiple sclerosis	0.00128	0.005	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00127	0.00494	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GPR65—multiple sclerosis	0.00123	0.00479	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00121	0.00469	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CNR1—multiple sclerosis	0.00119	0.00461	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—RGS1—multiple sclerosis	0.00118	0.00459	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00113	0.00438	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR1—multiple sclerosis	0.00113	0.00438	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GPR65—multiple sclerosis	0.00112	0.00435	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00109	0.00423	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LINGO1—multiple sclerosis	0.00108	0.00421	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL10—multiple sclerosis	0.00107	0.00415	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR1—multiple sclerosis	0.00102	0.00398	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL13—multiple sclerosis	0.00102	0.00398	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00102	0.00396	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TAGAP—multiple sclerosis	0.000938	0.00365	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL5—multiple sclerosis	0.000919	0.00357	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00085	0.0033	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000831	0.00323	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR5—multiple sclerosis	0.000828	0.00322	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—S1PR1—multiple sclerosis	0.00082	0.00319	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GPC5—multiple sclerosis	0.000798	0.0031	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000773	0.00301	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000746	0.0029	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL3—multiple sclerosis	0.000729	0.00284	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000726	0.00282	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000702	0.00273	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RGS1—multiple sclerosis	0.000697	0.00271	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000678	0.00264	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CNR1—multiple sclerosis	0.00067	0.00261	CbGpPWpGaD
Travoprost—Visual impairment—Betamethasone—multiple sclerosis	0.000668	0.0009	CcSEcCtD
Travoprost—Mental disorder—Methylprednisolone—multiple sclerosis	0.000668	0.000899	CcSEcCtD
Travoprost—Erythema—Triamcinolone—multiple sclerosis	0.000665	0.000896	CcSEcCtD
Travoprost—Erythema—Methylprednisolone—multiple sclerosis	0.000664	0.000894	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GPR65—multiple sclerosis	0.000661	0.00257	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR2—multiple sclerosis	0.000659	0.00256	CbGpPWpGaD
Travoprost—Hypersensitivity—Azathioprine—multiple sclerosis	0.000656	0.000883	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000656	0.000883	CcSEcCtD
Travoprost—Malaise—Prednisolone—multiple sclerosis	0.000652	0.000878	CcSEcCtD
Travoprost—Dysgeusia—Triamcinolone—multiple sclerosis	0.000652	0.000877	CcSEcCtD
Travoprost—Nausea—Cladribine—multiple sclerosis	0.00065	0.000876	CcSEcCtD
Travoprost—Vertigo—Prednisolone—multiple sclerosis	0.00065	0.000875	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000649	0.00252	CbGpPWpGaD
Travoprost—Eye disorder—Betamethasone—multiple sclerosis	0.000648	0.000872	CcSEcCtD
Travoprost—Eye disorder—Dexamethasone—multiple sclerosis	0.000648	0.000872	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—POMC—multiple sclerosis	0.000647	0.00252	CbGpPWpGaD
Travoprost—Back pain—Triamcinolone—multiple sclerosis	0.000644	0.000866	CcSEcCtD
Travoprost—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000642	0.000864	CcSEcCtD
Travoprost—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000634	0.000853	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL2—multiple sclerosis	0.000633	0.00246	CbGpPWpGaD
Travoprost—Asthma—Methotrexate—multiple sclerosis	0.000631	0.000849	CcSEcCtD
Travoprost—Angiopathy—Dexamethasone—multiple sclerosis	0.000629	0.000847	CcSEcCtD
Travoprost—Angiopathy—Betamethasone—multiple sclerosis	0.000629	0.000847	CcSEcCtD
Travoprost—Hypertension—Prednisolone—multiple sclerosis	0.000625	0.000841	CcSEcCtD
Travoprost—Fatigue—Mitoxantrone—multiple sclerosis	0.000621	0.000835	CcSEcCtD
Travoprost—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000617	0.000831	CcSEcCtD
Travoprost—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000616	0.000829	CcSEcCtD
Travoprost—Pain—Mitoxantrone—multiple sclerosis	0.000615	0.000829	CcSEcCtD
Travoprost—Constipation—Mitoxantrone—multiple sclerosis	0.000615	0.000829	CcSEcCtD
Travoprost—Bradycardia—Prednisone—multiple sclerosis	0.000615	0.000828	CcSEcCtD
Travoprost—Diarrhoea—Azathioprine—multiple sclerosis	0.000609	0.00082	CcSEcCtD
Travoprost—Discomfort—Prednisolone—multiple sclerosis	0.000609	0.000819	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CNR1—multiple sclerosis	0.000609	0.00237	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR1—multiple sclerosis	0.000605	0.00235	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL13—multiple sclerosis	0.000605	0.00235	CbGpPWpGaD
Travoprost—Erythema—Dexamethasone—multiple sclerosis	0.000604	0.000813	CcSEcCtD
Travoprost—Erythema—Betamethasone—multiple sclerosis	0.000604	0.000813	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000603	0.00235	CbGpPWpGaD
Travoprost—Malaise—Triamcinolone—multiple sclerosis	0.0006	0.000808	CcSEcCtD
Travoprost—Malaise—Methylprednisolone—multiple sclerosis	0.000599	0.000806	CcSEcCtD
Travoprost—Vertigo—Triamcinolone—multiple sclerosis	0.000598	0.000805	CcSEcCtD
Travoprost—Vertigo—Methylprednisolone—multiple sclerosis	0.000596	0.000803	CcSEcCtD
Travoprost—Connective tissue disorder—Prednisone—multiple sclerosis	0.000593	0.000799	CcSEcCtD
Travoprost—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000593	0.000798	CcSEcCtD
Travoprost—Oedema—Prednisolone—multiple sclerosis	0.00059	0.000795	CcSEcCtD
Travoprost—Dysuria—Methotrexate—multiple sclerosis	0.00059	0.000794	CcSEcCtD
Travoprost—Dizziness—Azathioprine—multiple sclerosis	0.000589	0.000793	CcSEcCtD
Travoprost—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000589	0.000792	CcSEcCtD
Travoprost—Cough—Triamcinolone—multiple sclerosis	0.000581	0.000782	CcSEcCtD
Travoprost—Tachycardia—Prednisolone—multiple sclerosis	0.000576	0.000776	CcSEcCtD
Travoprost—Hypertension—Triamcinolone—multiple sclerosis	0.000574	0.000773	CcSEcCtD
Travoprost—Hypertension—Methylprednisolone—multiple sclerosis	0.000573	0.000772	CcSEcCtD
Travoprost—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000569	0.000766	CcSEcCtD
Travoprost—Myalgia—Triamcinolone—multiple sclerosis	0.000566	0.000763	CcSEcCtD
Travoprost—Arthralgia—Methylprednisolone—multiple sclerosis	0.000565	0.000761	CcSEcCtD
Travoprost—Myalgia—Methylprednisolone—multiple sclerosis	0.000565	0.000761	CcSEcCtD
Travoprost—Eye disorder—Prednisone—multiple sclerosis	0.000564	0.00076	CcSEcCtD
Travoprost—Anxiety—Methylprednisolone—multiple sclerosis	0.000563	0.000758	CcSEcCtD
Travoprost—Infestation—Methotrexate—multiple sclerosis	0.000562	0.000757	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—multiple sclerosis	0.000562	0.000757	CcSEcCtD
Travoprost—Rash—Azathioprine—multiple sclerosis	0.000561	0.000756	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000561	0.000756	CcSEcCtD
Travoprost—Dermatitis—Azathioprine—multiple sclerosis	0.000561	0.000755	CcSEcCtD
Travoprost—Depression—Methotrexate—multiple sclerosis	0.000561	0.000755	CcSEcCtD
Travoprost—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00056	0.000754	CcSEcCtD
Travoprost—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00056	0.000754	CcSEcCtD
Travoprost—Discomfort—Triamcinolone—multiple sclerosis	0.00056	0.000753	CcSEcCtD
Travoprost—Discomfort—Methylprednisolone—multiple sclerosis	0.000558	0.000752	CcSEcCtD
Travoprost—Headache—Azathioprine—multiple sclerosis	0.000558	0.000751	CcSEcCtD
Travoprost—Dry mouth—Triamcinolone—multiple sclerosis	0.000554	0.000746	CcSEcCtD
Travoprost—Angiopathy—Prednisone—multiple sclerosis	0.000548	0.000738	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000548	0.00213	CbGpPWpGaD
Travoprost—Conjunctivitis—Methotrexate—multiple sclerosis	0.000547	0.000736	CcSEcCtD
Travoprost—Immune system disorder—Prednisone—multiple sclerosis	0.000546	0.000734	CcSEcCtD
Travoprost—Malaise—Dexamethasone—multiple sclerosis	0.000544	0.000733	CcSEcCtD
Travoprost—Malaise—Betamethasone—multiple sclerosis	0.000544	0.000733	CcSEcCtD
Travoprost—Oedema—Triamcinolone—multiple sclerosis	0.000543	0.000731	CcSEcCtD
Travoprost—Vertigo—Dexamethasone—multiple sclerosis	0.000542	0.00073	CcSEcCtD
Travoprost—Vertigo—Betamethasone—multiple sclerosis	0.000542	0.00073	CcSEcCtD
Travoprost—Infection—Triamcinolone—multiple sclerosis	0.000539	0.000726	CcSEcCtD
Travoprost—Infection—Methylprednisolone—multiple sclerosis	0.000538	0.000725	CcSEcCtD
Travoprost—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000531	0.000715	CcSEcCtD
Travoprost—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00053	0.000714	CcSEcCtD
Travoprost—Tachycardia—Triamcinolone—multiple sclerosis	0.00053	0.000713	CcSEcCtD
Travoprost—Mental disorder—Prednisone—multiple sclerosis	0.000529	0.000712	CcSEcCtD
Travoprost—Nausea—Azathioprine—multiple sclerosis	0.000529	0.000712	CcSEcCtD
Travoprost—Tachycardia—Methylprednisolone—multiple sclerosis	0.000529	0.000712	CcSEcCtD
Travoprost—Skin disorder—Methylprednisolone—multiple sclerosis	0.000526	0.000708	CcSEcCtD
Travoprost—Erythema—Prednisone—multiple sclerosis	0.000526	0.000708	CcSEcCtD
Travoprost—Hypertension—Betamethasone—multiple sclerosis	0.000521	0.000702	CcSEcCtD
Travoprost—Hypertension—Dexamethasone—multiple sclerosis	0.000521	0.000702	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000519	0.00202	CbGpPWpGaD
Travoprost—Asthenia—Mitoxantrone—multiple sclerosis	0.000516	0.000695	CcSEcCtD
Travoprost—Myalgia—Dexamethasone—multiple sclerosis	0.000514	0.000692	CcSEcCtD
Travoprost—Myalgia—Betamethasone—multiple sclerosis	0.000514	0.000692	CcSEcCtD
Travoprost—Anxiety—Betamethasone—multiple sclerosis	0.000512	0.00069	CcSEcCtD
Travoprost—Anxiety—Dexamethasone—multiple sclerosis	0.000512	0.00069	CcSEcCtD
Travoprost—Discomfort—Betamethasone—multiple sclerosis	0.000508	0.000684	CcSEcCtD
Travoprost—Discomfort—Dexamethasone—multiple sclerosis	0.000508	0.000684	CcSEcCtD
Travoprost—Hypotension—Methylprednisolone—multiple sclerosis	0.000506	0.000682	CcSEcCtD
Travoprost—Pain—Prednisolone—multiple sclerosis	0.000505	0.00068	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—multiple sclerosis	0.000501	0.000674	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000499	0.00194	CbGpPWpGaD
Travoprost—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000498	0.000671	CcSEcCtD
Travoprost—Vision blurred—Prednisone—multiple sclerosis	0.000495	0.000667	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—multiple sclerosis	0.000495	0.000666	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000495	0.000666	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000494	0.000665	CcSEcCtD
Travoprost—Oedema—Dexamethasone—multiple sclerosis	0.000493	0.000663	CcSEcCtD
Travoprost—Oedema—Betamethasone—multiple sclerosis	0.000493	0.000663	CcSEcCtD
Travoprost—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000492	0.000663	CcSEcCtD
Travoprost—Infection—Betamethasone—multiple sclerosis	0.000489	0.000659	CcSEcCtD
Travoprost—Infection—Dexamethasone—multiple sclerosis	0.000489	0.000659	CcSEcCtD
Travoprost—Ill-defined disorder—Prednisone—multiple sclerosis	0.000488	0.000657	CcSEcCtD
Travoprost—Feeling abnormal—Prednisolone—multiple sclerosis	0.000487	0.000655	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—multiple sclerosis	0.000486	0.000655	CcSEcCtD
Travoprost—Dyspnoea—Triamcinolone—multiple sclerosis	0.000484	0.000652	CcSEcCtD
Travoprost—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000483	0.00065	CcSEcCtD
Travoprost—Nervous system disorder—Betamethasone—multiple sclerosis	0.000483	0.00065	CcSEcCtD
Travoprost—Tachycardia—Dexamethasone—multiple sclerosis	0.000481	0.000647	CcSEcCtD
Travoprost—Tachycardia—Betamethasone—multiple sclerosis	0.000481	0.000647	CcSEcCtD
Travoprost—Dyspepsia—Triamcinolone—multiple sclerosis	0.000478	0.000643	CcSEcCtD
Travoprost—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000477	0.000642	CcSEcCtD
Travoprost—Malaise—Prednisone—multiple sclerosis	0.000474	0.000638	CcSEcCtD
Travoprost—Vertigo—Prednisone—multiple sclerosis	0.000472	0.000636	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—multiple sclerosis	0.000472	0.000635	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCL5—multiple sclerosis	0.000472	0.00183	CbGpPWpGaD
Travoprost—Tinnitus—Methotrexate—multiple sclerosis	0.000471	0.000634	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—multiple sclerosis	0.000468	0.000631	CcSEcCtD
Travoprost—Fatigue—Triamcinolone—multiple sclerosis	0.000468	0.00063	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000468	0.00182	CbGpPWpGaD
Travoprost—Fatigue—Methylprednisolone—multiple sclerosis	0.000467	0.000629	CcSEcCtD
Travoprost—Pain—Triamcinolone—multiple sclerosis	0.000464	0.000625	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000461	0.00179	CbGpPWpGaD
Travoprost—Hypotension—Dexamethasone—multiple sclerosis	0.00046	0.00062	CcSEcCtD
Travoprost—Hypotension—Betamethasone—multiple sclerosis	0.00046	0.00062	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—multiple sclerosis	0.000458	0.000616	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—multiple sclerosis	0.000456	0.000614	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000455	0.000612	CcSEcCtD
Travoprost—Hypertension—Prednisone—multiple sclerosis	0.000454	0.000611	CcSEcCtD
Travoprost—Rash—Mitoxantrone—multiple sclerosis	0.000454	0.000611	CcSEcCtD
Travoprost—Dermatitis—Mitoxantrone—multiple sclerosis	0.000453	0.00061	CcSEcCtD
Travoprost—Headache—Mitoxantrone—multiple sclerosis	0.000451	0.000607	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000449	0.000604	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000449	0.000604	CcSEcCtD
Travoprost—Arthralgia—Prednisone—multiple sclerosis	0.000448	0.000603	CcSEcCtD
Travoprost—Myalgia—Prednisone—multiple sclerosis	0.000448	0.000603	CcSEcCtD
Travoprost—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000447	0.000602	CcSEcCtD
Travoprost—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000446	0.000601	CcSEcCtD
Travoprost—Anxiety—Prednisone—multiple sclerosis	0.000446	0.0006	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000445	0.000598	CcSEcCtD
Travoprost—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000443	0.000596	CcSEcCtD
Travoprost—Discomfort—Prednisone—multiple sclerosis	0.000442	0.000595	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—multiple sclerosis	0.000442	0.000595	CcSEcCtD
Travoprost—Erythema—Methotrexate—multiple sclerosis	0.000439	0.000591	CcSEcCtD
Travoprost—Hypersensitivity—Prednisolone—multiple sclerosis	0.000435	0.000586	CcSEcCtD
Travoprost—Dyspepsia—Dexamethasone—multiple sclerosis	0.000434	0.000584	CcSEcCtD
Travoprost—Dyspepsia—Betamethasone—multiple sclerosis	0.000434	0.000584	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCL3—multiple sclerosis	0.000431	0.00167	CbGpPWpGaD
Travoprost—Dysgeusia—Methotrexate—multiple sclerosis	0.00043	0.000579	CcSEcCtD
Travoprost—Oedema—Prednisone—multiple sclerosis	0.000429	0.000578	CcSEcCtD
Travoprost—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000428	0.000577	CcSEcCtD
Travoprost—Nausea—Mitoxantrone—multiple sclerosis	0.000428	0.000576	CcSEcCtD
Travoprost—Infection—Prednisone—multiple sclerosis	0.000426	0.000574	CcSEcCtD
Travoprost—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000425	0.000573	CcSEcCtD
Travoprost—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000425	0.000573	CcSEcCtD
Travoprost—Back pain—Methotrexate—multiple sclerosis	0.000425	0.000572	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCR5—multiple sclerosis	0.000425	0.00165	CbGpPWpGaD
Travoprost—Fatigue—Betamethasone—multiple sclerosis	0.000425	0.000572	CcSEcCtD
Travoprost—Fatigue—Dexamethasone—multiple sclerosis	0.000425	0.000572	CcSEcCtD
Travoprost—Pain—Dexamethasone—multiple sclerosis	0.000421	0.000567	CcSEcCtD
Travoprost—Pain—Betamethasone—multiple sclerosis	0.000421	0.000567	CcSEcCtD
Travoprost—Nervous system disorder—Prednisone—multiple sclerosis	0.000421	0.000566	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000419	0.00163	CbGpPWpGaD
Travoprost—Tachycardia—Prednisone—multiple sclerosis	0.000419	0.000564	CcSEcCtD
Travoprost—Skin disorder—Prednisone—multiple sclerosis	0.000417	0.000561	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PTGER4—multiple sclerosis	0.000415	0.00161	CbGpPWpGaD
Travoprost—Vision blurred—Methotrexate—multiple sclerosis	0.000414	0.000557	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PGR—multiple sclerosis	0.000408	0.00159	CbGpPWpGaD
Travoprost—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000408	0.000549	CcSEcCtD
Travoprost—Feeling abnormal—Betamethasone—multiple sclerosis	0.000406	0.000547	CcSEcCtD
Travoprost—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000406	0.000547	CcSEcCtD
Travoprost—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000403	0.000542	CcSEcCtD
Travoprost—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000403	0.000542	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CXCR3—multiple sclerosis	0.0004	0.00156	CbGpPWpGaD
Travoprost—Hypersensitivity—Triamcinolone—multiple sclerosis	0.0004	0.000539	CcSEcCtD
Travoprost—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000399	0.000537	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CD28—multiple sclerosis	0.000397	0.00154	CbGpPWpGaD
Travoprost—Malaise—Methotrexate—multiple sclerosis	0.000396	0.000533	CcSEcCtD
Travoprost—Vertigo—Methotrexate—multiple sclerosis	0.000395	0.000531	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000391	0.000526	CcSEcCtD
Travoprost—Dizziness—Prednisolone—multiple sclerosis	0.00039	0.000526	CcSEcCtD
Travoprost—Asthenia—Triamcinolone—multiple sclerosis	0.00039	0.000524	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCR2—multiple sclerosis	0.00039	0.00151	CbGpPWpGaD
Travoprost—Abdominal pain—Betamethasone—multiple sclerosis	0.000389	0.000524	CcSEcCtD
Travoprost—Abdominal pain—Dexamethasone—multiple sclerosis	0.000389	0.000524	CcSEcCtD
Travoprost—Asthenia—Methylprednisolone—multiple sclerosis	0.000389	0.000523	CcSEcCtD
Travoprost—Pruritus—Triamcinolone—multiple sclerosis	0.000384	0.000517	CcSEcCtD
Travoprost—Cough—Methotrexate—multiple sclerosis	0.000383	0.000516	CcSEcCtD
Travoprost—Pruritus—Methylprednisolone—multiple sclerosis	0.000383	0.000516	CcSEcCtD
Travoprost—Dyspepsia—Prednisone—multiple sclerosis	0.000378	0.000508	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—multiple sclerosis	0.000374	0.000504	CcSEcCtD
Travoprost—Chest pain—Methotrexate—multiple sclerosis	0.000374	0.000504	CcSEcCtD
Travoprost—Myalgia—Methotrexate—multiple sclerosis	0.000374	0.000504	CcSEcCtD
Travoprost—Rash—Prednisolone—multiple sclerosis	0.000372	0.000501	CcSEcCtD
Travoprost—Dermatitis—Prednisolone—multiple sclerosis	0.000372	0.000501	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000371	0.0005	CcSEcCtD
Travoprost—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000371	0.000499	CcSEcCtD
Travoprost—Fatigue—Prednisone—multiple sclerosis	0.00037	0.000498	CcSEcCtD
Travoprost—Headache—Prednisolone—multiple sclerosis	0.00037	0.000498	CcSEcCtD
Travoprost—Discomfort—Methotrexate—multiple sclerosis	0.00037	0.000498	CcSEcCtD
Travoprost—Constipation—Prednisone—multiple sclerosis	0.000367	0.000494	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—POMC—multiple sclerosis	0.000366	0.00142	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CNR1—multiple sclerosis	0.000359	0.0014	CbGpPWpGaD
Travoprost—Dizziness—Triamcinolone—multiple sclerosis	0.000359	0.000483	CcSEcCtD
Travoprost—Dizziness—Methylprednisolone—multiple sclerosis	0.000358	0.000482	CcSEcCtD
Travoprost—Infection—Methotrexate—multiple sclerosis	0.000356	0.00048	CcSEcCtD
Travoprost—Feeling abnormal—Prednisone—multiple sclerosis	0.000354	0.000476	CcSEcCtD
Travoprost—Asthenia—Dexamethasone—multiple sclerosis	0.000353	0.000476	CcSEcCtD
Travoprost—Asthenia—Betamethasone—multiple sclerosis	0.000353	0.000476	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—multiple sclerosis	0.000352	0.000473	CcSEcCtD
Travoprost—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000351	0.000472	CcSEcCtD
Travoprost—Nausea—Prednisolone—multiple sclerosis	0.000351	0.000472	CcSEcCtD
Travoprost—Pruritus—Dexamethasone—multiple sclerosis	0.000349	0.000469	CcSEcCtD
Travoprost—Pruritus—Betamethasone—multiple sclerosis	0.000349	0.000469	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—multiple sclerosis	0.000348	0.000469	CcSEcCtD
Travoprost—Rash—Triamcinolone—multiple sclerosis	0.000342	0.000461	CcSEcCtD
Travoprost—Dermatitis—Triamcinolone—multiple sclerosis	0.000342	0.00046	CcSEcCtD
Travoprost—Rash—Methylprednisolone—multiple sclerosis	0.000342	0.00046	CcSEcCtD
Travoprost—Dermatitis—Methylprednisolone—multiple sclerosis	0.000341	0.000459	CcSEcCtD
Travoprost—Headache—Triamcinolone—multiple sclerosis	0.00034	0.000458	CcSEcCtD
Travoprost—Headache—Methylprednisolone—multiple sclerosis	0.000339	0.000457	CcSEcCtD
Travoprost—Abdominal pain—Prednisone—multiple sclerosis	0.000339	0.000457	CcSEcCtD
Travoprost—Diarrhoea—Dexamethasone—multiple sclerosis	0.000337	0.000454	CcSEcCtD
Travoprost—Diarrhoea—Betamethasone—multiple sclerosis	0.000337	0.000454	CcSEcCtD
Travoprost—Hypotension—Methotrexate—multiple sclerosis	0.000335	0.000451	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—POMC—multiple sclerosis	0.000332	0.00129	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000327	0.00044	CcSEcCtD
Travoprost—Dizziness—Betamethasone—multiple sclerosis	0.000326	0.000439	CcSEcCtD
Travoprost—Dizziness—Dexamethasone—multiple sclerosis	0.000326	0.000439	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCL2—multiple sclerosis	0.000325	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL10—multiple sclerosis	0.000324	0.00126	CbGpPWpGaD
Travoprost—Nausea—Triamcinolone—multiple sclerosis	0.000323	0.000434	CcSEcCtD
Travoprost—Nausea—Methylprednisolone—multiple sclerosis	0.000322	0.000433	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—multiple sclerosis	0.00032	0.00043	CcSEcCtD
Travoprost—Hypersensitivity—Prednisone—multiple sclerosis	0.000316	0.000426	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—multiple sclerosis	0.000316	0.000425	CcSEcCtD
Travoprost—Rash—Betamethasone—multiple sclerosis	0.000311	0.000418	CcSEcCtD
Travoprost—Rash—Dexamethasone—multiple sclerosis	0.000311	0.000418	CcSEcCtD
Travoprost—Dermatitis—Dexamethasone—multiple sclerosis	0.00031	0.000418	CcSEcCtD
Travoprost—Dermatitis—Betamethasone—multiple sclerosis	0.00031	0.000418	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00031	0.000417	CcSEcCtD
Travoprost—Fatigue—Methotrexate—multiple sclerosis	0.000309	0.000416	CcSEcCtD
Travoprost—Headache—Betamethasone—multiple sclerosis	0.000309	0.000416	CcSEcCtD
Travoprost—Headache—Dexamethasone—multiple sclerosis	0.000309	0.000416	CcSEcCtD
Travoprost—Asthenia—Prednisone—multiple sclerosis	0.000308	0.000414	CcSEcCtD
Travoprost—Pain—Methotrexate—multiple sclerosis	0.000307	0.000413	CcSEcCtD
Travoprost—Pruritus—Prednisone—multiple sclerosis	0.000304	0.000409	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—multiple sclerosis	0.000295	0.000398	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—TYK2—multiple sclerosis	0.000295	0.00115	CbGpPWpGaD
Travoprost—Diarrhoea—Prednisone—multiple sclerosis	0.000294	0.000395	CcSEcCtD
Travoprost—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000293	0.000395	CcSEcCtD
Travoprost—Nausea—Dexamethasone—multiple sclerosis	0.000293	0.000394	CcSEcCtD
Travoprost—Nausea—Betamethasone—multiple sclerosis	0.000293	0.000394	CcSEcCtD
Travoprost—Dizziness—Prednisone—multiple sclerosis	0.000284	0.000382	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—multiple sclerosis	0.000283	0.000382	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CD86—multiple sclerosis	0.000283	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL5—multiple sclerosis	0.000279	0.00108	CbGpPWpGaD
Travoprost—Rash—Prednisone—multiple sclerosis	0.000271	0.000364	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—IL2—multiple sclerosis	0.00027	0.00105	CbGpPWpGaD
Travoprost—Dermatitis—Prednisone—multiple sclerosis	0.00027	0.000364	CcSEcCtD
Travoprost—Headache—Prednisone—multiple sclerosis	0.000269	0.000362	CcSEcCtD
Travoprost—Hypersensitivity—Methotrexate—multiple sclerosis	0.000264	0.000356	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SPP1—multiple sclerosis	0.000258	0.001	CbGpPWpGaD
Travoprost—Asthenia—Methotrexate—multiple sclerosis	0.000257	0.000346	CcSEcCtD
Travoprost—Nausea—Prednisone—multiple sclerosis	0.000255	0.000343	CcSEcCtD
Travoprost—Pruritus—Methotrexate—multiple sclerosis	0.000254	0.000342	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCR5—multiple sclerosis	0.000251	0.000976	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL2RA—multiple sclerosis	0.000247	0.000962	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL2—multiple sclerosis	0.000246	0.000955	CbGpPWpGaD
Travoprost—Diarrhoea—Methotrexate—multiple sclerosis	0.000245	0.00033	CcSEcCtD
Travoprost—Dizziness—Methotrexate—multiple sclerosis	0.000237	0.000319	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—APOE—multiple sclerosis	0.000228	0.000888	CbGpPWpGaD
Travoprost—Rash—Methotrexate—multiple sclerosis	0.000226	0.000304	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—multiple sclerosis	0.000226	0.000304	CcSEcCtD
Travoprost—Headache—Methotrexate—multiple sclerosis	0.000225	0.000302	CcSEcCtD
Travoprost—Nausea—Methotrexate—multiple sclerosis	0.000213	0.000287	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CD80—multiple sclerosis	0.000206	0.000803	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—multiple sclerosis	0.000196	0.000763	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL2—multiple sclerosis	0.000192	0.000746	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000188	0.00073	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TYK2—multiple sclerosis	0.000174	0.000678	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL2—multiple sclerosis	0.000145	0.000564	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—multiple sclerosis	0.000144	0.000561	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—multiple sclerosis	0.000137	0.000534	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT3—multiple sclerosis	0.000122	0.000475	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—multiple sclerosis	0.000113	0.000441	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—multiple sclerosis	0.000113	0.00044	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK1—multiple sclerosis	0.000111	0.000431	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—multiple sclerosis	8.53e-05	0.000331	CbGpPWpGaD
